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Abstract
A type III secretion system (T3SS) in pathogenic Yersinia species functions to translocate Yop effectors, which modulate
cytokine production and regulate cell death in macrophages. Distinct pathways of T3SS-dependent cell death and caspase-1
activation occur in Yersinia-infected macrophages. One pathway of cell death and caspase-1 activation in macrophages
requires the effector YopJ. YopJ is an acetyltransferase that inactivates MAPK kinases and IKKb to cause TLR4-dependent
apoptosis in naı ¨ve macrophages. A YopJ isoform in Y. pestis KIM (YopJ
KIM) has two amino acid substitutions, F177L and
K206E, not present in YopJ proteins of Y. pseudotuberculosis and Y. pestis CO92. As compared to other YopJ isoforms,
YopJ
KIM causes increased apoptosis, caspase-1 activation, and secretion of IL-1b in Yersinia-infected macrophages. The
molecular basis for increased apoptosis and activation of caspase-1 by YopJ
KIM in Yersinia-infected macrophages was
studied. Site directed mutagenesis showed that the F177L and K206E substitutions in YopJ
KIM were important for enhanced
apoptosis, caspase-1 activation, and IL-1b secretion. As compared to YopJ
CO92, YopJ
KIM displayed an enhanced capacity to
inhibit phosphorylation of IkB-a in macrophages and to bind IKKb in vitro. YopJ
KIM also showed a moderately increased
ability to inhibit phosphorylation of MAPKs. Increased caspase-1 cleavage and IL-1b secretion occurred in IKKb-deficient
macrophages infected with Y. pestis expressing YopJ
CO92, confirming that the NF-kB pathway can negatively regulate
inflammasome activation. K
+ efflux, NLRP3 and ASC were important for secretion of IL-1b in response to Y. pestis KIM
infection as shown using macrophages lacking inflammasome components or by the addition of exogenous KCl. These data
show that caspase-1 is activated in naı ¨ve macrophages in response to infection with a pathogen that inhibits IKKb and
MAPK kinases and induces TLR4-dependent apoptosis. This pro-inflammatory form of apoptosis may represent an early
innate immune response to highly virulent pathogens such as Y. pestis KIM that have evolved an enhanced ability to inhibit
host signaling pathways.
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Introduction
Microbial pathogens encode numerous types of virulence factors
that are used to circumvent or usurpimmune responses within cellsof
their hosts. A protein export pathway known as the type III secretion
system (T3SS) allows Gram-negative bacterial pathogens to deliver
effector proteins into or across the plasma membrane of host cells,
with the goal of co-opting or disrupting eukaryotic signaling pathways
[1,2]. Infection of macrophages with T3SS-expressing bacterial
pathogens commonly causes cytotoxicity in the host cell, but the
mechanisms of cellular demise and the morphological and
immunological characteristics of cell death can be unique for each
microbe [3]. Two types of macrophage death that can be induced by
T3SS-expressing pathogens and distinguished morphologically and
immunologically are apoptosis and pyroptosis [4]. Apoptosis is
traditionally associated with a lack of inflammation while pyroptosis is
considered pro-inflammatory [4,5]. Apoptosisand pyroptosis can also
be distinguished mechanistically by the fact that only the latter
mechanism of cell death is dependent upon the activity of caspase-1, a
pro-inflammatory caspase [4,5]. Recently, however it has been
determined that caspase-1 can be activated in macrophages dying of
apoptosis [6,7,8], indicating that pathogen-inflicted apoptosis may
not be immunologically silent.
Caspase-1 is synthesized as a 45 kDa inactive zymogen that is
cleaved to generate the active heterotetramer composed of two
p10 and two p20 subunits [9]. Activation of caspase-1 occurs
PLoS Pathogens | www.plospathogens.org 1 April 2011 | Volume 7 | Issue 4 | e1002026through its recruitment to an inflammasome complex [10,11,12].
Activated caspase-1 cleaves pro-IL-1b and pro-IL-18, and
promotes secretion of the mature forms of these cytokines by a
non-conventional pathway. Macrophages dying of pyroptosis
therefore release active forms of IL-1b, and IL-18, which are
important cytokines for protective host responses against several
pathogens [5]. In addition, pyroptosis can release intracellular
bacteria from macrophages, allowing for clearance of the
pathogens by neutrophils [13].
Inflammasome complexes assemble on a scaffold of NOD-like
receptors (NLRs) [11,12,14]. NLRs comprise a family of pattern
recognition receptors (PRRs) that detect cytosolic pathogen-
associated molecular patterns (PAMPs) or infection-associated
processes [10,11,12]. Well-studied NLR family members include
NLRP3 (formerly NALP3 or Cryopyrin), NLRC4 (formerly IPAF)
and NAIP5. NLRP3 in complex with the adaptor protein ASC
induces the activation of caspase-1 in response to a variety of
microbial products as well as endogenous danger signals such as
potassium (K
+) efflux or extracellular ATP [10,11,12]. NLRC4
recognizes bacterial flagellin from S. enterica serovar Typhimurium,
which is delivered into macrophages via a T3SS in this pathogen
[10,13,15,16,17]. Another family of PRRs, the toll-like receptors
(TLRs) often function in concert with NLRs to positively regulate
inflammasome activation and function [18]. For example,
production of pro-IL-1b and pro-IL-18 is upregulated by TLR
signaling. In addition, production of NLRP3 is positively regulated
by TLR signaling through the NF-kB pathway [19].
In pathogenic Yersinia species, a plasmid-encoded T3SS delivers
Yop effectors into host cells [2], allowing the bacteria to modulate
innate immune responses [20]. The T3SS is an essential virulence
determinant in these pathogens, which cause diseases ranging
from plague (Y. pestis) to enterocolitis (Y. enterocolitica) and
mesenteric lymphadenitis (Y. pseudotuberculosis). Naı ¨ve Yersinia-
infected macrophages undergo apoptosis via a cell death program
that requires TLR4-dependent activation of initiator and execu-
tioner caspases and T3SS-mediated delivery of YopJ, which
inhibits expression of anti-apoptotic factors under regulatory
control of MAPK and NF-kB signaling pathways [21,22,23,24].
Inactivation of the NF-kB and MAPK signaling pathways via
YopJ-mediated inhibition of the inhibitor of kappa B kinase beta
(IKKb) and MAPK kinases (MKKs) is critical for apoptosis of
Yersinia-infected macrophages [23,25].
YopJ is the prototypical member of a family of T3SS effectors
that inhibit the NF-kB pathway [26,27,28]. These proteins exhibit
homology to CE cysteine proteases [26]. Evidence has been
obtained that YopJ can function as a deubiquitinase [29,30,31].
However, more recent studies indicate that YopJ has acetyltrans-
ferase activity, acetylating Ser and Thr residues critical for the
activation of the MKKs and IKKb [32,33,34]. YopJ is an
important virulence factor in Y. pseudotuberculosis [21,35] and Y.
enterocolitica, where it is known as YopP [36].
Recently, it has been determined that caspase-1 can be
activated in a T3SS-dependent manner by two distinct pathways
in macrophages infected with Yersinia [6]. In one pathway,
insertion of channels or pores in the plasma membrane by the
T3SS translocon activates caspase-1 and causes pyroptosis in
Yersinia-infected macrophages [6,37,38,39]. Activation of caspase-1
in response to the Yersinia T3SS translocon can be counteracted by
Yop effectors including YopE [39] and YopK [6], and therefore
this pathway is inhibited in macrophages infected with wild-type
bacteria.
A second pathway of caspase-1 activation that occurs in
macrophages infected with wild-type Yersinia is not inhibited by
YopE or YopK and requires YopJ activity [6,8]. Although
caspase-1 is activated in response to YopJ activity, caspase-1 is
not required for YopJ-dependent macrophage apoptosis [6,8]. A
potential explanation for the ability of YopJ to cause caspase-1
activation came from the work of Greten et al. [7], who showed
that genetic or pharmacological ablation of IKKb resulted in
apoptosis, activation of caspase-1 and secretion of IL-1b from
macrophages following stimulation of TLR4 with LPS. Evidence
was obtained that an anti-apoptosis gene product expressed under
control of NF-kB, plasminogen activator inhibitor 2 (PAI-2),
negatively regulates apoptosis and caspase-1 activation in LPS-
stimulated macrophages [7]. The authors suggested that inhibition
of caspase-1 by the NF-kB pathway represents a negative feedback
loop that allows the innate immune system to activate, via TLR4,
a compensatory host defense response against Gram-negative
pathogens that inhibit activation of NF-kB [7].
Different Yersinia strains display a range of YopJ-dependent
apoptotic activities on macrophages [8,35,40,41]. This difference
in apoptotic activity is due to the expression of distinct YopJ
isoforms by different Yersinia strains [8,35,40,41]. For example, a Y.
enterocolitica strain encoding a YopP protein with an Arg at position
143 was shown to have higher apoptotic activity and inhibit IKKb
more efficiently in macrophages then strains having a Ser at this
position [40]. Y. pestis KIM, a 2.MED (Mediaevalis) biovar strain,
encodes a YopJ isoform that causes higher levels of apoptosis and
caspase-1 activation in infected macrophages as compared to other
YopJ isoforms [8]. The YopJ
KIM protein has an Arg at position
143 but in addition has two amino acid substitutions, at positions
177 and 206, as compared to other isoforms of this effector found
in Y. pestis or Y. pseudotuberculosis strains.
Here, the molecular basis for the enhanced ability of YopJ
KIM
to cause apoptosis and activate caspase-1 in Yersinia-infected
macrophages was studied, with the goal of better understanding
the underlying mechanism of this host response. Analysis of
YopJ
KIM in parallel with other YopJ isoforms indicated that the
unique capacity of this effector to cause high-level apoptosis and
caspase-1 activation requires both codon substitutions at positions
177 and 206. The presence of these codon substitutions also
correlated with the enhanced ability of YopJ
KIM to inhibit MKK
Author Summary
Pathogenic bacteria in the genus Yersinia use multiple
virulence determinants to counteract innate immunity and
facilitate infection. A type III system in Yersinia translocates
an effector called YopJ that elicits cell death in macro-
phages. YopJ inhibits the production of survival factors in
naı ¨ve macrophages, causing them to die by apoptosis,
which is generally considered to be immunologically silent.
However, recent studies show that caspase-1, a key
regulator of pro-inflammatory responses, is activated in
Yersinia-infected macrophages undergoing apoptosis.
How caspase-1 is activated during YopJ-induced macro-
phage apoptosis is not known. We have identified a
distinct isoform of YopJ in Y. pestis (YopJ
KIM) that induces
high levels of apoptosis and caspase-1 activation in
infected macrophages. In this study, the molecular basis
for the increased activity of YopJ
KIM was studied with the
goal of better understanding the underlying mechanism of
caspase-1 activation. The data show that YopJ
KIM has two
amino acid changes that give it an enhanced ability to
inhibit survival signals in macrophages. The increased
apoptosis may cause membrane permeability, resulting in
efflux of ions and activation of caspase-1. Therefore,
apoptosis of naı ¨ve macrophages inflicted by highly
virulent pathogens may not be immunologically silent.
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macrophages with Y. pestis confirmed that this kinase has an
important role in negatively regulating caspase-1 activation [7].
Finally, evidence was obtained that K
+ efflux leading to activation
of the NLRP3/ASC/capsase-1 inflammasome is important for
secretion of IL-1b and IL-18 from macrophages infected with Y.
pestis KIM. These findings indicate that, by inhibiting production
of survival factors under control of the NF-kB and MAPK
pathways, YopJ causes TLR4-dependent apoptosis and caspase-1
activation in macrophages infected with Yersinia. In addition, Y.
pestis KIM causes high levels of apoptosis and caspase-1 activation
in macrophages because it has evolved a YopJ isoform with
enhanced inhibitory activity on NF-kB and MAPK pathways.
Results
Identification of amino acid substitutions in YopJ that
increase MyD88- and Trif-dependent caspase-1 activation
in Yersinia-infected macrophages
Sequence comparisons were made between YopJ
KIM and YopJ
proteins from two other Yersinia strains that display lower apoptosis
activity in macrophages, Y. pseudotuberculosis IP2666 and Y. pestis
CO92. There is one amino acid difference between YopJ
KIM and
YopJ in Y. pseudotuberculosis (YopJ
YPTB), corresponding to L177F in
the predicted catalytic core [29] of the enzyme (residues 109-194;
Figure S1 in Text S1). Comparison of YopJ
KIM with YopJ from Y.
pestis CO92 (YopJ
CO92) revealed two differences, L177F and
E206K, the latter of which is located just beyond the carboxy-
terminal end of the predicted catalytic core (Figure S1 in Text S1).
To determine if the amino acid substitutions at positions 177
and 206 of YopJ
KIM affect secretion or delivery of the effector into
macrophages, expression plasmids encoding YopJ
KIM, YopJ
YPTB,
or YopJ
CO92 appended with C-terminal GSK tags were
constructed. An expression plasmid encoding a YopJ isoform with
a Leu at position 177 and a Lys at position 206 (YopJ
KIME206K)
was also constructed in the same manner. The expression plasmids
were introduced into a DyopJ mutant of Y. pseudotuberculosis (IP26;
Table S1 in Text S1). Y. pseudotuberculosis was used in the
experiment because it lacks the Pla protease of Y. pestis which is
known to degrade Yops secreted in vitro [42]. The resulting strains
were induced to secrete Yops under low calcium growth
conditions and immunoblotting of the secreted proteins showed
that YopJ
KIM, YopJ
YPTB, YopJ
KIME206K and YopJ
CO92 were
exported at equal levels (Figure S2 in Text S1).
A translocation assay was performed using the phospho-GSK
reporter system [43]. IP26 strains expressing the different YopJ
isoforms fused to GSK were used to infect bone marrow derived
macrophages (BMDMs) for 2 hr. Delivery of the effector into host
cells was measured by anti-phospho-GSK immunoblotting [43].
The results showed that YopJ
KIM, YopJ
YPTB, YopJ
KIME206K and
YopJ
CO92 isoforms were translocated at similar levels (Figure 1A).
Samples of the same lysates analyzed in Figure 1A were subjected
to immunoblotting with anti-caspase-1 antibody to measure the
level of caspase-1 cleavage. Consistent with previous results [6],
cleavage of caspase-1 was detected in BMDMs infected with Y.
pseudotuberculosis expressing YopJ
YPTB (Figure 1B, lane 2). Howev-
er, caspase-1 cleavage was comparatively higher with expression of
YopJ
KIM (lane 1) and lower with expression of YopJ
KIME206K or
YopJ
CO92 isoforms (lanes 3 and 4, respectively). These results
suggest that the ability of YopJ
KIM to trigger maximal caspase-1
activation requires both the F177L and K206E substitutions, and
these codon changes impart an activity to the protein that is
manifested following its delivery into the host cell.
YopJ-mediated apoptosis in response to Yersinia infection
requires stimulation of TLR4 in naı ¨ve macrophages to activate a
death response pathway [25,44]. It is not known if TLR signaling
is required for YopJ-dependent activation of caspase-1 in Yersinia-
infected macrophages. When BMDMs lacking the two major TLR
adaptors, MyD88 and Trif, were infected with wild-type Y.
pseudotuberculosis IP2666 for 2 hr, activation of caspase-1 was
substantially reduced (Figure S3 in Text S1). Cleavage of caspase-1
was not diminished in IP2666-infected BMDMs missing only
MyD88 or Trif (data not shown), indicating that TLR signaling
through either of these adaptors is important for the downstream
events that lead to activation of caspase-1 in conjunction with
YopJ activity. YopJ-dependent caspase-1 activation and IL-1b
secretion were inhibited when BMDMs were treated with LPS
prior to infection with Y. pseudotuberculosis (Figure S3 in Text S1) [6]
or Y. pestis [8]. Thus, macrophages pre-stimulated with LPS are
desensitized to undergo YopJ-dependent apoptosis [38] and
caspase-1 activation upon Yersinia infection. Desensitization occurs
because the TLR4 signaling pathway contains a negative feed
back mechanism operating via NF-kB that upregulates expression
of proteins that inhibit apoptosis and activation of caspase-1 [7].
The F177L and K206E substitutions in YopJ
KIM are
important for increased apoptosis and secretion of IL-1b
and IL-18 in Y. pestis-infected macrophages
To demonstrate that the polymorphisms in YopJ
KIM at
positions 177 and 206 were important for the activity of this
effector in the native context of Y. pestis, a L177F codon change
was introduced into the sequence of yopJ
KIM on the virulence
Figure 1. Translocation of different YopJ isoforms and caspase-
1 activation in macrophages infected with Y. pseudotuberculosis.
Y. pseudotuberculosis IP26 (IP2666DyopJ) carrying no pBAD plasmid as a
control (CTL; lane 5) or pBAD vectors encoding the indicated YopJ-GSK
isoforms (lanes 1–4), were grown under T3SS-inducing conditions in the
presence of 0.2% of arabinose. Bacteria were added to BMDMs at an
MOI of 20 and were allowed to infect for 2 hr. Arabinose (0.2%) was
maintained in cell culture medium. Detergent lysates of infected
macrophages were separated by SDS-PAGE and immunoblotting was
performed with anti-phospho-GSK-3H antibody (A) and anti-caspase-1
antibody (B). Positions of molecular weight standards (kDa) are shown
on the left and positions of YopJ- phospho-GSK and cleaved caspase-1
are shown on the right.
doi:10.1371/journal.ppat.1002026.g001
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YPTB.I n
addition, an E206K codon change, a double L177F/E206K
codon change, and a C172A codon change were introduced into
pCD1, creating yopJ
KIME206K, yopJ
C092, and yopJ
C172A, respectively.
The resulting strains (referred to as Yp-YopJ
YPTB, Yp-YopJ
KIME206K,
Yp-YopJ
C092 and Yp-YopJ
C172A)(Table S1 in Text S1) were
phenotypically analyzed. As shown by immunoblotting of whole
bacterial lysates, YopJ
KIM,Y o p J
YPTB, YopJ
KIME206K and YopJ
CO92
were expressed at equal levels in Y. pestis (Figure S4 in Text S1). The
ability of Y. pestis strains expressing the different YopJ isoforms to
induce apoptosis and cytokine secretion in BMDMs was then
determined after a 24 hr infection. As shown in Figure 2A,B, the
amounts of lactate dehydrogenase (LDH) released (used as a
marker of cell death) and IL-1b secreted were significantly lower
in macrophages infected with Yp-YopJ
YPTB, Yp-YopJ
KIME206K or
Yp-YopJ
CO92 as compared to Yp-YopJ
KIM. A similar trend was seen
for secretion of IL-18 (Figure 2C).
Caspase-1 was required for the processing and release of IL-1b
from macrophages under these infection conditions as shown by
infecting wild-type or casp-1
-/- BMDMs with Yp-YopJ
KIM and
isolating IL-1b from infection supernatants by immunoprecipita-
tion. Mature IL-1b was absent in supernatants isolated from
casp-1
-/- BMDMs infected with Yp-YopJ
KIM (Figure S5 in Text
S1), indicating that the processing and release of IL-1b during
infection of wild-type macrophages with Yp-YopJ
KIM occurred in
a caspase-1-dependent manner.
As a control, levels of TNF-a, which is secreted independent of
caspase-1 activity, were measured. Macrophages infected with Yp-
YopJ
C172A or Yp-YopJ
CO92 secreted significantly higher levels of
TNF-a as compared to Yp-YopJ
KIM, whereas the other mutants
tested produced intermediate results (Figure 2D). Overall, these
results indicate that amino acid substitutions at positions 177 and
206 are important for the ability of YopJ
KIM to induce high levels
of macrophage apoptosis, caspase-1 activation and secretion of
mature IL-1b and IL-18 in Y. pestis-infected macrophages.
Conversely, the amino acid substitutions at positions 177 and
206 are important for the ability of YopJ
KIM to inhibit TNF-a
secretion in macrophages under the same conditions.
YopJ
KIM binds to IKKb with higher affinity and more
efficiently inhibits phosphorylation of IkBa as compared
to YopJ
CO92
To determine if YopJ
KIM has higher affinity for IKKb as
compared to other YopJ isoforms, several different YopJ proteins
were assayed for the ability to bind this kinase in cell lysates.
Purified GST-YopJ fusion proteins or GST alone bound to beads
Figure 2. Cytokine secretion and cell death in macrophages infected with Y. pestis strains expressing different YopJ isoforms.
BMDMs were left uninfected (U), or infected with the indicated Yp-YopJ strains at an MOI of 10. Supernatants collected after 24 hr of infection were
used to measure cell death by LDH release (A) and secretion of IL-1b (B), IL-18 (C) and TNF-a (D) by ELISA. Results shown are the average of three
independent experiments. Error bars represent standard deviation. Bracketing indicates P values (ANOVA) between different conditions.
doi:10.1371/journal.ppat.1002026.g002
Inflammasome Activation by YopJKIM in Macrophages
PLoS Pathogens | www.plospathogens.org 4 April 2011 | Volume 7 | Issue 4 | e1002026were incubated in HEK293T cell lysates that contained
overexpressed IKKb. The amounts of IKKb and GST proteins
recovered on the beads after washing was measured by
quantitative immunoblotting. IKKb bound to beads coated with
GST-YopJ
KIM but not to beads coated with GST alone (Figure 3A,
compare lanes 2 and 3). There was reduced binding of IKKb to
GST-YopJ
CO92 as compared to GST-YopJ
KIM (Figure 3A,
compare lanes 3 and 5). When the amount of bound IKKb was
normalized to the amount of GST fusion protein recovered, it was
estimated that 10-times less IKKb bound to GST-YopJ
CO92 as
compared to GST-YopJ
KIM (Figure 3B). A GST fusion protein
encoding YopJ
C172A bound ,5 times less IKKb as compared to
GST-YopJ
KIM (Figure 3A, compare lanes 3 and 4, Figure 3B),
suggesting that the catalytic Cys residue contributes to binding
between IKKb and YopJ
KIM. Overall, these results suggest that
YopJ
KIM has higher affinity for IKKb as compared to YopJ
CO92.
To determine if YopJ
KIM i sab e t t e ri n h i b i t o ro fI K K b than
YopJ
CO92, the amount of phosphorylated IkBa (p-IkBa) in BMDMs
was measured after a 1 hr infection. As shown in Figure 3C,
significantly lower levels of p-IkBa were present in macrophages
infected with Yp-YopJ
KIM ascomparedtoBMDMsinfectedwithYp-
YopJ
CO92.I na d d i t i o n ,s i g n i f i c a n t l yl o w e rl e v e l so fp - I kBa were
present in macrophages infected with Yp-YopJ
KIM as compared to
BMDMs infected with Yp-YopJ
C172A (Fig. 3C), confirming that
acetyltransferase activity is important for YopJ to inhibit the NF-kB
pathway. Because IkBa is directly phosphorylated by IKKb,t h e s e
results are consistent with the idea that YopJ
KIM more efficiently
inhibits IKKb activity as compared to YopJ
CO92.
Partial genetic ablation of IKKb increases caspase-1
activation in Y. pestis-infected macrophages
Greten et al. have shown that treatment of IKKb-deficient
macrophages with LPS causes activation of caspase-1 and
secretion of IL-1b [7]. If IKKb activity is important to suppress
activation of the inflammasome in macrophages infected with a
live Gram-negative pathogen, than increased caspase-1 activation
and IL-1b secretion should be observed in IKKb-deficient as
compared to wild-type BMDMs infected with Y. pestis. The effect
of genetic inactivation of Ikkb on caspase-1 activation in Y. pestis-
infected macrophages was therefore investigated. IKKb-deficient
BMDMs were generated by conditional Cre-lox-mediated deletion
of a ‘‘floxed’’ Ikkb gene (referred to as Ikkb
D BMDMs; Materials
and Methods). The Ikkb
D BMDMs or wild-type control Ikkb
F/F
macrophages were left uninfected or infected with Yp-YopJ
KIM,
Yp-YopJ
CO92 or Yp-YopJ
C172A for 4 hr. Quantitative RT-PCR
(qRT-PCR) of Ikkb message was used to estimate the efficiency of
Cre-lox mediated deletion of the Ikkb gene in the BMDMs. Results
indicated that ,50% of the Ikkb genes had been deleted in the
population of Ikkb
D cells (Figure S6A in Text S1). The impact of
this partial deficiency in Ikkb on the expression and secretion of
cytokines in the Y. pestis infected macrophages was determined. As
compared to the Ikkb
F/F macrophages, the Ikkb
D BMDMs were
compromised for infection-induced expression of mRNA for the
cytokines IL-18, TNFa and IL-1b, as shown by qRT-PCR (Figure
S6B–D in Text S1). This result was expected since the NF-kB
pathway positively regulates expression the il-18, tnf and il-1b
genes. Accordingly, the Ikkb
D BMDMs secreted lower levels of
TNFa as compared to Ikkb
F/F macrophages after a 24 hr infection
(Figure 4A). In addition, during infection with Yp-YopJ
CO92 or
Yp-YopJ
C172A, higher amounts of IL-1b were secreted from Ikkb
D
Figure 3. Measurement of IKKb binding to different YopJ
isoforms and phospho-IkBa levels in macrophages infected
with different Y. pestis strains. (A) Binding of IKKb to different YopJ
isoforms as determined using a GST pull down procedure and lysates of
transfected HEK293T cells. Purified proteins corresponding to GST (lane
2) or the indicated GST-YopJ fusion proteins (lanes 3–5) were
immobilized on beads and incubated in cell lysates containing
overexpressed IKKb. After washing, proteins bound to the beads were
detected and the signals quantified by immunoblotting using
antibodies to IKKb or GST and an Odyssey imaging system. Lane 1
contains a sample of the input transfected cell lysate (Input). Positions
of molecular weight standards (kDa) are shown on the left and positions
of IKKb, GST-YopJ, and GST proteins are shown on the right. (B) Ratios
of the signals for IKKb and GST obtained by immunoblotting are
presented in bar graph format, with values representing averages of
two independent experiments. (C) BMDMs were left uninfected (U) or
infected with Yp-YopJ
KIM, Yp-YopJ
C172A or Yp-YopJ
CO92 at an MOI of 50.
At 1 hr post infection lysates of the infected macrophages were
prepared and subjected to ELISA to determine levels of phospho (p)-
IkBa. Results show p-IkBa values normalized to arbitrary units by
setting uninfected to 1. Results were averaged from six (uninfected and
Yp-YopJ
KIM) or three (Yp-YopJ
C172A and Yp-YopJ
CO92) independent
experiments and error bars represent standard deviations. P value,0.05
(t test) as compared to Yp-YopJ
KIM condition is indicated by (*).
doi:10.1371/journal.ppat.1002026.g003
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F/F macrophages (Figure 4B),
consistent with the idea that the NF-kB pathway negatively
regulates processing and secretion of IL-1b via control of caspase-1
activation [7]. Unexpectedly, the amount of IL-1b secreted
following infection with Yp-YopJ
KIM appeared to be lower in
Ikkb
D BMDMs as compared to Ikkb
F/F macrophages, although the
observed difference was not statistically significant (Figure 4B).
The interpretation of this latter result was complicated because of
the fact that there was only partial deficiency in Ikkb in the Ikkb
D
BMDMs, but one possible explanation was that synthesis of pro-
IL-1b was reduced due to the extremely low level il-1b message in
the Ikkb
D BMDMs infected with Yp-YopJ
KIM (Figure S6D in Text
S1).
Activation of caspase-1 was measured by immunoblotting to
detect the cleaved enzyme in lysates prepared 2 hr after infection
of Ikkb
D or Ikkb
F/F BMDMs with Yp-YopJ
KIM, Yp-YopJ
CO92 or
Yp-YopJ
C172A. Caspase-1 activation in uninfected BMDMs or in
macrophages treated with LPS and ATP was determined in
parallel for comparison. Increased caspase-1 cleavage occured in
Ikkb
D macrophages infected with Yp-YopJ
KIM or Yp-YopJ
CO92 as
compared to Ikkb
F/F BMDMs infected with the same strains
(Figure 5A, compare lanes 7 and 8 with 2 and 3). Cleaved caspase-
1 was below the limit of detection in Ikkb
D macrophages infected
with Yp-YopJ
C172A (Figure 5A, lane 9). Activation of caspase-1
was also measured by a microscopic assay utilizing FAM-YVAD-
FMK, a fluorescent probe for active caspase-1, in Ikkb
D or Ikkb
F/F
BMDMs infected for 9 hr. The results showed overall higher levels
of caspase-1 positive cells in Ikkb
D as compared to Ikkb
F/F
macrophages (Figure 5B and C). Taken together, these results
show that loss of IKKb activity can increase caspase-1 activation
in macrophages infected with Y. pestis, and are consistent with the
idea that IKKb is an important target of YopJ for activation of the
inflammasome.
YopJ
KIM more efficiently inhibits activation of MAPKs as
compared to YopJ
CO92
In addition to binding to and acetylating IKKb, YopJ binds to
and acetylates other members of the MKK superfamily including
MKK1, MKK2, MKK3, MKK4, MKK5, and MKK6 [26,32,33].
There is evidence that YopJ binds toa site conserved onmembers of
the MKK-IKK superfamily [45]. Since we had previously obtained
evidence that inhibition of MAPK signaling was critical for YopJ-
induced macrophage apoptosis [23], we sought to determine if
YopJ
KIM could more efficiently inhibit MAPK phosphorylation as
compared to YopJ
CO92. BMDMs were left uninfected or infected
for 30 or 60 min with Yp-YopJ
KIM, Yp-YopJ
CO92,o rY p -
YopJ
C172A and ELISA was used to measure phosphorylation of
the MAPKs ERK (substrate of MKK1/2), p38 (substrate of
MKK3/6) and SAPK/JNK (substrate of MKK4/7) (Materials and
Methods). As shown in Figure 6A, ERK was not phosphorylated to
a large degreeat either time point inmacrophages infected with Yp-
YopJ
C172A andtherefore itwas not possibletoevaluatethedegreeto
which ERK phosphorylation was inhibited by either YopJ
KIM or
Yp-YopJ
CO92. In contrast, p38 and JNK did show increased
phosphorylation upon infection with Yp-YopJ
C172A, especially at
the 30 min time point (Figure 6B and C, respectively). There was in
general reduced phosphorylation of p38 and JNK in BMDMs
infected with Yp-YopJ
KIM as compared to YopJ
CO92, especially at
the 30 min time point, and the difference was statistically significant
in the case of JNK (Figure 6B and C). These results suggest that
YopJ
KIM more efficiently inhibits the activities of MKK3/6 and
MKK4/7 as compared to YopJ
CO92.
The NLRP3/ASC/caspase-1 inflammasome is important
for secretion of IL-1b and IL-18 from macrophages
infected with Yp-YopJ
KIM
The importance of several different inflammasome components
for Y. pestis-induced secretion of IL-1b and IL-18 was investigated
using NLRP3 (Nlrp3
-/-)-, ASC (Asc
-/-)- or NLRC4 (Nlrc4
-/-)-
deficient BMDMs. The mutant BMDMs or wild-type control
macrophages were infected with Yp-YopJ
KIM or Yp-YopJ
C172A.
Tissue culture supernatants were collected and analyzed by ELISA
to measure the levels of IL-1b and IL-18 present after 24 hr of
infection. NLRP3- or ASC-deficient BMDMs infected with Yp-
YopJ
KIM secreted significantly lower levels of IL-1b and IL-18 as
compared to wild-type macrophages infected with Yp-YopJ
KIM
(Figure 7A,B; Figure S7A, B in Text S1). NLRC4-deficient
macrophages released similar levels of these cytokines as compared
to wild-type BMDMs (Figure 7A, Figure S7A in Text S1),
suggesting that NLRC4 does not play a significant role in caspase-
1 activation and cytokine secretion during Yp-YopJ
KIM infection.
Both Yp-YopJ
KIM and Yp-YopJ
C172A stimulated infected BMDMs
to secrete TNF-a, although higher levels (,2 to 3 fold) of TNF-a
were secreted from macrophages infected with Yp-YopJ
C172A
regardless of macrophage type infected (Figure 7C, D). Thus,
NLRP3 and ASC, but not NLRC4, are involved in the secretion
Figure 4. IL-1b and TNF-a secretion in Ikkb
F/F or Ikkb
D
macrophages infected with Y. pestis strains expressing differ-
ent YopJ isoforms. Ikkb
F/F or Ikkb
D macrophages were left uninfected
(U) or infected with the indicated Yp-YopJ strains at an MOI of 10.
Twenty-four hr post infection, cell supernatants were collected.
Secreted TNF-a (A) and IL-1b (B) were measured by ELISA. Results
were averaged from three independent experiments, and error bars
represent standard deviation. P values (t test) are indicated by
bracketing (P,0.05 (*), P,0.01 (**), P,0.001(***).
doi:10.1371/journal.ppat.1002026.g004
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KIM -infected
macrophages.
YopJ
KIM-induced macrophage apoptosis does not require
NLRP3, ASC or NLRC4
To determine if NLRP3, NLRC4 or ASC play a role in
YopJ
KIM-dependent apoptosis, wild-type BMDMs or BMDMs
deficient for these inflammasome components were left uninfected
or infected with Yp-YopJ
KIM or Yp-YopJ
C172A. Tissue culture
supernatants were collected 24 hr post-infection and analyzed for
LDH. Similar levels of LDH were released from NLRP3, NLRC4
or ASC-deficient BMDMs as compared wild-type macrophages
after Yp-YopJ
KIM infection (Figure 7E, F). Low levels of LDH
release occurred in all macrophages infected with Yp-YopJ
C172A.
Figure 5. Caspase-1 activation in Ikkb
F/F or Ikkb
D macrophages infected with Y. pestis strains expressing different YopJ isoforms. Ikkb
F/F
orIkkb
DBMDMswereleftuninfected(U)orinfectedwiththeindicatedYp-YopJstrainsatanMOIof20(A)or10(BandC),ortreatedwithLPSfor3 hrand
then exposed to ATP (LPS/ATP). (A) Caspase-1 cleavage was determined at 1 hr post ATP treatment or 2 hr post infection. In (A) samples of detergent
lysates were separated by SDS-PAGE and immunoblotted with anti-caspase-1 antibody (upper panel) or anti-actin antibody antibody (lower panel).
Positions of molecular weight standards (kDa) are shown on the left and positions of cleaved caspase-1 and actin are shown on the right. In (B)
uninfectedorinfectedmacrophagesoncoverslipswereincubatedwithFLICAreagent(FAM-YVAD-FMK)at9 hrpostinfectiontostainforactivecaspase-
1 (green fluorescence). The samples were fixed, mounted on slides, and light microscopy was used to detect phase (a–d, i–l) or fluorescence (e-h, m-p)
signals. Representative images of uninfected or infected cells were captured by digital photomicroscopy. White arrows point to FLICA positive cells. In
(C), average percentages (error bars show standard deviation) of FLICA positive cells counted from three random fields per coverslip in three
independent experiments is shown. P values comparing results of infection in Ikkb
D to Ikkb
F/F BMDMs was determined (P,0.01, **; P,0.001, ***).
doi:10.1371/journal.ppat.1002026.g005
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KIM
-infected macrophages in the absence of NLRP3, NLRC4 or ASC,
consistent with our previous data showing that macrophage
apoptosis during Yp-YopJ
KIM infection is independent of caspase-
1 [8].
Evidence that K
+ efflux is important for secretion of IL-1b
and IL-18 from macrophages infected with Yp-YopJ
KIM
Efflux of intracellular K
+ has been implicated in
the activation of the NLRP3/ASC/caspase-1 inflammasome
[10,11,12]. To assess a role for intracellular K
+ efflux in
caspase-1 activation and IL-1b release during infection with Y.
pestis, BMDMs were infected with Yp-YopJ
KIM or Yp-YopJ
C172A,
and then incubated in cell culture media supplemented with
30 mM KCl, 30 mM NaCl or no supplement. Cell culture
supernatants were collected at 8 hr and 24 hr time points and
analyzed for the presence of IL-1b and TNF-a by ELISA.
Significantly lower levels of IL-1b (,5-fold) were secreted from
macrophages infected with Yp-YopJ
KIM in the presence of 30 mM
KCl as compared to untreated macrophages at 8 hr post-infection
(Figure 8A). Macrophages infected with Yp-YopJ
KIM in the
presence of 30 mM NaCl appeared to secrete IL-1b to slightly
lower levels as compared to untreated infected macrophages at
8 hr post-infection, but this difference was not significant
(Figure 8A). A similar trend of IL-1b secretion was observed at
the 24 hr time point when macrophages were infected with Yp-
YopJ
KIM in the presence or absence of KCl or NaCl (Figure 8C).
Macrophages infected with Yp-YopJ
C172A secreted similar low
levels of IL-1b regardless of treatment (Figure 8A, C). Secretion of
TNF-a from Yp-YopJ
KIM- or Yp-YopJ
C172A-infected macrophag-
es was not affected by the presence of 30 mM KCl or NaCl
(Figure 8B, D). In addition, the presence of 30 mM KCl did not
diminish LDH release from BMDMs infected with Yp-YopJ
KIM
(data not shown). BMDMs deficient for the purinergic receptor,
P2X7, secreted similar levels of IL-1b and IL-18 as did wild-type
macrophages infected with Yp-YopJ
KIM, indicating that this
receptor does not play a significant role in inducing the secretion
of these cytokines (data not shown). Taken together, these results
suggest that a K
+ efflux that occurs independent of P2X7Ri s
important for activation of the NLRP3/ASC/caspase-1 inflam-
masome in macrophages infected with Yp-YopJ
KIM.
To examine how Y. pestis infection and KCl treatment affected
steady state levels of pro-IL-1b, lysates of macrophages left
untreated or treated with KCl or NaCl were prepared at 8 hr post-
infection and analyzed by immunoblotting for pro-IL-1b or actin
as a loading control. As shown in Figure 8E, infection stimulated
production of pro-IL-1b, with steady state levels of pro-IL-1b
slightly lower in macrophages infected with Yp-YopJ
KIM as
compared to Yp-YopJ
C172A (compare lanes 2 and 3, 5 and 6
and 8 and 9). Similar amounts of pro-IL-1b were detected in
macrophages infected with Yp-YopJ
KIM in the absence or
presence of 30 mM KCl or 30 mM NaCl (Figure 8E, compare
lane 2 with 5 and 8). These results indicated that reduced detection
of IL-1b in supernatants of macrophages infected with YopJ
KIM
and treated with exogenous KCl was not due to KCl inhibiting
production of pro-IL-1b.
Discussion
It was previously shown that caspase-1 was activated during
YopJ-induced apoptosis of macrophages infected with Y. pseudo-
tuberculosis [6]. In addition, it was demonstrated that YopJ
KIM had
increased capacity to cause macrophage apoptosis and activate
caspase-1 as compared to other YopJ isoforms [8]. However, the
mechanism of YopJ-induced caspase-1 activation and the
molecular basis for enhanced apoptosis and activation of
caspase-1 in macrophages by YopJ
KIM was unknown. The results
of studies reported here indicate that several of the requirements
for YopJ-induced apoptosis and caspase-1 activation are the same,
and therefore it is likely that these two processes are mechanis-
Figure 6. Measurement of phospho-MAPK levels in macro-
phages infected with Y. pestis strains expressing different YopJ
isoforms. BMDMs were left uninfected (U), or infected with the
indicated Yp-YopJ strains at an MOI of 20. At 30 or 60 min post
infection lysates of the infected macrophages were prepared and
subjected to ELISA to determine levels of phospho-ERK (A), -p38 (B) or –
SAPK/JNK (C). Results show OD450 values averaged from three
(uninfected, Yp-YopJ
KIM and Yp-YopJ
CO92) or two (Yp-YopJ
C172A)
independent experiments and error bars represent standard deviations.
P value (*, ,0.05) (t test) is indicated by bracket.
doi:10.1371/journal.ppat.1002026.g006
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important for YopJ-induced macrophage apoptosis [21,22,23,24]
and we show here that the two major TLR adaptors, MyD88 and
Trif, are important for YopJ-induced caspase-1 activation. Second,
desensitization of macrophages by pretreatment with LPS
decreases YopJ-induced apoptosis [38] and caspase-1 activation.
Third, comparison of the activities of different YopJ isoforms
showed a direct correlation between apoptosis, caspase-1 activa-
tion and inhibition of MAPK and NF-kB signaling pathways.
Forth, when macrophages in which Ikkb was conditionally deleted
were infected with Y. pestis, caspase-1 activation increased,
providing genetic evidence that IKKb is an important target of
YopJ for caspase-1 activation, as well as apoptosis [25].
Inhibition of MAPK and NF-kB pathways by YopJ is thought
to reduce expression of survival factors (e.g. FLIP, XIAP), thereby
potentiating TLR4 signaling to trigger apoptosis [22,23,24].
Inactivation of the MAPK and NF-kB pathways by YopJ could
also prevent expression of putative negative regulators of caspase-
1 (e.g. PAI-2) [7]. It is important to point out that there is no
direct evidence that PAI-2 inhibits caspase-1 activation indepen-
dently of blocking apoptosis, rather the data show that PAI-2
overexpression reduces both apoptosis and caspase-1 activation
[7]. It is possible that PAI-2 inhibits apoptosis and that events
triggered downstream of TLR4-dependent programmed cell
death are required for caspase-1 activation. We suggest that
caspase-1 activation is a normal outcome of a type of apoptosis
that is triggered in naı ¨ve macrophages by TLR4 signaling
combined with pathogen interference with MAPK and NF-kB
pathways.
Data presented here suggest that YopJ
KIM triggers increased
apoptosis and caspase-1 activation because it is a better
inhibitor of macrophage survival pathways than other YopJ
isoforms. YopJ
KIM could function as a better inhibitor of
macrophage signaling pathways if it had a longer half-life in the
host cell, or had higher affinity for substrates. The F177L
polymorphism could increase protein stability, although it is not
immediately clear why a Leu at position 177 rather than a Phe
would increase protein half-life. The K206E mutation could
increase half-life, which is reasonable since Lys residues can be
subject to ubiquitination. Although not mutually exclusive of
the preceding ideas, we favor the hypothesis that the F177L and
K206E substitutions allow YopJ
KIM to bind more tightly to
substrates, thereby making acetylation of targets more efficient
at limiting enzyme concentrations. We obtained two pieces of
evidence supporting this hypothesis. First, YopJ
KIM had higher
apparent affinity for IKKb than YopJ
CO92 when these
interactions were measured in cell lysates by a GST pull down
assay. Second, macrophages infected with Yp-YopJ
KIM had
lower levels of phosphorylated IkBa and MAPKs as compared
to macrophages infected with Yp-YopJ
CO92, indicating that
there was increased inhibition of IKKb and MAPK kinase
activity by Yp-YopJ
KIM.
The results suggest a model whereby the canonical yopJ allele
in Y. pseudotuberculosis (yopJ
YPTB) was inherited by an ancestral Y.
Figure 7. Determination of the importance of inflammasome components for cytokine secretion and cell death in infected
macrophages.Wild-typeBMDMs, orBMDMsdeficientforNLRC4 (Ipaf),ASC(ASC)orNLRP3(Nalp3) were left uninfected(U)orinfectedwith Yp-YopJ
KIM
or Yp-YopJ
C172A at an MOI of 10. Supernatants were collected at 24 hr post-infection and analyzed by ELISA to quantify amounts of secreted IL-1b (A, B)
or TNF-a (C, D). Cell death was measured by LDH release (E, F). Results shown are the average of three independent experiments. Error bars represent
standard deviation. Statistical significance compared to YP-YopJ
KIM-infected wild-type BMDMs was determined (ANOVA; P,0.05, *; P,0.01, **).
doi:10.1371/journal.ppat.1002026.g007
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with higher apoptotic and caspase-1-activating potential, YopJ-
KIM, by the F177L mutation. The predicted sequence of a YopJ
protein in Y. pestis biovar 2.MED strain K1973002 (ZP_02318615)
is identical to the sequence of YopJ
KIM, suggesting that the
phenotype observed is not an artifact resulting from a mutation
acquired during laboratory passage, but is associated with a
unique yopJ genotype associated with 2.MED strains. It is also
hypothesize that the yopJ
CO92 allele evolved from yopJ
YPTB to
encode an isoform with lower cytotoxic and caspase-1 activating
potential (YopJ
CO92) by the E206K codon substitution. How
these polymorphisms in YopJ affect Y. pestis virulence and or
the host response is not known but is an important question to
address in future studies.
Figure 8. Determination of the effect of exogenous KCl on cytokine expression and secretion in infected macrophages. BMDMs were
left uninfected (U) or infected at an MOI of 10 with Yp-YopJ
KIM or Yp-YopJ
C172A and treated with 30 mM KCl (K+), 30 mM NaCl (Na+) or left untreated
(Media) asindicated.Supernatantswerecollectedat8 hr (A,B)or24 hr(C,D)post-infection,andsecretedIL-1b(A,C)andTNF-a (B,D)weremeasuredby
ELISA. (E) Pro-IL-1b in cell lysates prepared at 8 hr post-infection was detected by immunoblotting with anti-IL-1b antibody. Actin in the same samples
was detected by immunoblotting as a loading control. Results shown in A–D are the average of three independent experiments. Error bars represent
standard deviation. Statistical significance compared to YP-YopJ
KIM-infected BMDMs in media alone was determined (ANOVA; P,0.01, **; P,0.001, ***).
doi:10.1371/journal.ppat.1002026.g008
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YopJ-dependent activation of caspase-1 in macrophages infected
with Y. pseudotuberculosis has recently been examined [6]. This
study showed that NLRP3 and ASC were not required for
activation of caspase-1 as measured by immunoblot analysis of
caspase-1 cleavage [6]. Those results would appear to be in
conflict with findings presented here showing a role for NLRP3
and ASC in secretion of IL-1b and IL-18 from macrophages
infected with Yp-YopJ
KIM. However, recent studies suggest that
multiple distinct caspase-1 activation pathways with different
biological outcomes can operate in macrophages infected with a
bacterial pathogen. For example, evidence has been obtained
that Legionella pneumophila stimulates two distinct pathways of
caspase-1 activation in macrophages [46]. ASC is required for
secretion of active IL-18 from L. pneumophila-infected macro-
phages, but is not required for caspase-1 dependent induction of
pyroptosis [46]. In addition, the multiplicity and temporal stage
of infection of macrophages with a bacterial pathogen can affect
the requirements for cell death and activation of caspase-1.
Shigella flexneri infection of macrophages at low MOI (,10) for
short periods of time induces NLRC4-dependent pyroptosis
[47,48], while infection at higher MOI (50) for longer time
periods induces NLRP3-dependent pyronecrosis [48]. Two
different infection procedures for examining YopJ-induced
caspase-1 activation in macrophages have been used in this
study and previous publications [6,8]. A high MOI (20) followed
by 1 hr of bacterial-host cell contact before addition of
gentamicin results in detectable YopJ-dependent apoptosis and
caspase-1 activation within 2 hr of infection (Figure 5A, Figure
S3 in Text S1) [6] but no detectable secretion of IL-1b by this
time point (data not shown) [6] . A low MOI (10) followed by
20 min of bacterial-host cell contact before addition of
gentamicin results in detectable apoptosis and caspase-1
activation by 8–9 hr (Figure 5B,C) [8], at which time secreted
IL-1b and IL-18 are first detected [8]. High amounts of secreted
IL-1b and IL-18 are detected at 24 hr post infection under the
low MOI procedure (e.g. Figure 2) [8]. The high and low MOI
infection procedures may result in different requirements for
NLRs to activate caspase-1, as shown by a requirement for ASC
and NLRP3 in the latter but not former method. Interestingly,
the low MOI procedure appears to slow down the kinetics of
apoptosis and caspase-1 activation, which is likely important to
allow for synthesis of NLRP3 [19] and the pro-forms of IL-1b
and IL-18.
Under the low MOI conditions the presence of 30 mM KCl in
the infection medium inhibited the secretion of IL-1b and IL-18
from macrophages infected with Yp-YopJ
KIM, suggesting an
important role for K
+ efflux in caspase-1 activation. Efflux of
intracellular K
+ mediated by the P2X7R is critical for ATP-
induced caspase-1 activation in macrophages primed with LPS
[49]. However, like other NLRP3 activators such as nigericin,
caspase-1 activation in response to Yp-YopJ
KIM infection did not
require P2X7R. One possibility is that pore formation during
YopJ
KIM-induced apoptosis leads to K
+ efflux, resulting in
activation of the NALP3/ASC/caspase-1 inflammasome. One
limitation of this model is that it remains to be determined if K
+
efflux acts as a proximal activating signal of the NALP3/ASC/
caspase-1 inflammasome. A second limitation of this model is that
apoptosis is generally associated with maintenance of an intact
plasma membrane, until late stages of cell death [4]. Future
experiments will need to address the possibility that YopJ-induced
apoptosis of Yersinia-infected macrophages can be associated with
rapid membrane permeability, resulting in K
+ efflux and caspase-1
activation.
Materials and Methods
Ethics statement
All animal use procedures were conducted following the NIG
Guide for the Care and Use of Laboratory Animals and performed
in accordance with Institutional regulations after review and
approval by the Institutional Animal Care and Use Committee at
Stony Brook University.
Yersinia strains, plasmids and growth conditions
Y. pestis and Y. pseudotuberculosis strains used in this study are listed
in Table S1 in Text S1. Y. pestis strains used in this study are
derived from KIM5 [8], which lacks the pigmentation locus (pgm)
and are exempt from select agent guidelines and conditionally
attenuated. Introduction of codon changes into yopJ in KIM5
(Table S1 in Text S1) was performed using the suicide plasmid
pSB890 and allelic exchange as described [50]. The arabinose
inducible plasmid encoding YopJ
KIM (pYopJ-GSK) has been
described [43]). Codon changes were introduced into yopJ
KIM on
this plasmid using Quikchange (Invitrogen), yielding pYopJ
YPTB-
GSK, pYopJ
KIME206K-GSK, and pYopJ
CO92-GSK. The resulting
plasmids were used to transform IP26 (IP2666 DyopJ) using
electroporation and selection on LB agar plates containing
ampicillin (100 mg/ml) [8].
Bone marrow macrophage isolation and culture
conditions
Bone marrow derived macrophages (BMDM) were isolated
from the femurs of 6- to 8-week-old C57BL/6 female mice
(Jackson Laboratories), Casp-1
-/- mice [8], P2X7 receptor-deficient
mice [51], Ikkb
f/f or Ikkb
f/f;MLysCre mice [52,53], NLRC4-
(Nlrc4
-/-), ASC- (Asc
-/-) or NLRP3- (Nlrp3
-/-) deficient mice
[54], and MyD88-, Trif- and MyD88/Trif-deficient mice [55] and
cultured as previously described [56,57].
Macrophage infections for LDH release, cytokine ELISA,
IL-1b immunoblotting and FLICA
Y. pestis cultures were grown overnight with aeration in HI broth
at 28uC. The next day the cultures were diluted to an OD600 of 0.1
in the same medium supplemented with 2.5 mM CaCl2 and
incubated for 2 hr at 37uC with aeration. Twenty-four hours
before infection, BMDM were seeded into wells of 24-well plates at
a density of 1.5610
5 cells/ml. Macrophage infections were
performed in 37uC incubators with 5% CO2 at a multiplicity of
infection (MOI) of 10 as previously described [8]. After addition of
bacteria, plates were centrifuged for 5 minutes at 95 xg to induce
contact between bacteria and macrophages. After incubation at
37uC for 15 minutes, macrophages were washed once with pre-
warmed PBS to remove any bacteria that have not been taken up.
Fresh infection medium containing 8 mg/ml of gentamicin was
added for 1 hr at 37uC. After 1 hr, macrophages were washed
once with PBS and a lower concentration of gentamicin (4.5 mg/
ml) in fresh tissue culture media was added for the remaining
incubation times. To inhibit potassium efflux from infected
macrophages, potassium chloride (KCl) was added to a final
concentration of 30 mM concurrently with the media exchanges
containing 8 mg/ml gentamicin and 4.5 mg/ml gentamicin [8].
Sodium chloride (NaCl) was used as a control and added as above
at a concentration of 30 mM above baseline. Amounts of IL-1b,
TNF-a or IL-18 secreted into tissue culture media during infection
assays were measured by ELISA as described [8]. Supernatants
from infected macrophages were collected and analyzed for LDH
release as described [8]. Staining with 6-carboxyfluorescein–
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hibitor of apoptosis (FLICA)) (Immunochemistry Technologies) to
detect active caspase-1 in infected macrophages was performed
using fluorescence and phase microscopy as described [8] with the
exception that the procedure was performed 9 hr post-infection,
and the anti-Yersinia immunolabeling step was omitted. Quantifi-
cation of percent caspase-1 positive BMDMs was performed by
scoring macrophages for positive signal in three different randomly
selected fields (,50–100 cells per field) on a coverslip.
Immunoblotting for pro-IL-1b
At 8 hr post-infection, macrophage lysates from triplicate wells
were collected in 100 ml of 1X lysis buffer (50 mM Tris-HCl,
5 mM EDTA, 150 mM NaCl, 1% Triton X-100, 2 mM DTT
and a protease inhibitor cocktail [Complete Mini, EDTA-Free,
Roche]). Proteins were resolved by SDS-PAGE and transferred to
a nitrocellulose membrane. To detect IL-1b, membranes were
blotted with goat anti-IL-1b (R&D Systems). A secondary
antibody, Hamster anti-goat IRDye 700 antibody (Rockland)
was used to detect samples, and blots were viewed on the Odyssey
Infrared Imaging System (LI-COR). To control for loading, blots
were probed with a rabbit anti-actin antibody (Sigma-Aldrich).
Phospho-IkBa ELISA
BMDMs (10
6 cells per well) were seeded in 6-well plates. Y. pestis
cultures were grown as above and used to infect BMDM at a MOI
of 50. 1 hr post infection, cells were washed with ice-cold PBS and
incubated in 150 ul of 1X Lysis Buffer (Cell Signaling) for 5 min.
Cells were scraped on ice and sonicated twice for 5 seconds each.
Lysates were centrifuged at 4uC for 10 min and 100 mlo f
supernatant was used for ELISA. Phospho-IkBa levels were
determined using a PathScan Phospho-IkappaB-alpha (Ser32)
Sandwich ELISA kit according to manufacturer’s protocol (Cell
Signaling).
Macrophage infections for Phospho-MAPK ELISA
BMDMs (10
6 cells per well) were seeded in 6-well plates. Y. pestis
cultures were grown in HI at 28uC overnight and diluted 1:20 next
day in the same medium supplemented with 20 mM NaOX and
20 mM MgCl2. Cultures were shaken at 28uC for 1 hr and
switched to 37uC for 2 hr. Cells were infected at an MOI of 20
and incubated for 30 or 60 min without adding gentamicin.
Macrophages were harvested and lysed as above. The PathScan
MAP Kinase Multi-Target Sandwich ELISA kit was used to
determine phosphor-ERK, -p38 and –JNK levels according to
manufacturer’s instruction (Cell Signaling).
Macrophage infections for YopJ translocation and
caspase-1 cleavage assays
Y. pseudotuberculosis strains were grown in 2xYT at 26uC
overnight and diluted 1:40 in the same medium supplemented
with 20 mM NaOX, and 20 mM MgCl2. Cultures were shaken
at 26uC for 1 hr and shifted to 37uC for 2 hr. BMDMs were
seeded into wells of 6-well plates at a density of 10
6 cells/well.
Bacteria were harvested, washed with DMEM and added to
BMDMs at an MOI of 20. After 1 hr of infection gentamicin
was added to a final concentration of 100 mg/ml. To induce
expression of YopJ-GSK proteins, arabinose (0.2%) was
maintained during grown in 2xYT at 37uC and in the cell
culture medium used for infection. Y. pestis strains were grown
and used to infect macrophages as above except that HI broth
was used and arabinose was omitted. Two hr post-infection,
infected BMDMs were washed with PBS and lysed in buffer
containing 50 mM Tris-HCl pH 8.0, 5 mM EDTA, 2% Triton
X-100, and 0.02% sodium azide with protease inhibitors. In
some experiments the macrophages were incubated with 50 ng/
ml of LPS for 3 hrs and then exposed to ATP at final
concentration of 2.5 mM for 1 hr as a positive control for
caspase-1 cleavage. Proteins were resolved by 10% SDS-PAGE,
transferred to a PVDF membrane and probed with anti-
phospho-GSK-3b primary antibody (Cell Signaling). In some
experiments the blots were stripped and re-probed with rabbit
polyclonal anti-caspase-1 antibodies (Santa Cruz) or directly
developed with this antibody. As a loading control blots were
reprobed with an anti-actin antibody (Sigma-Aldrich, clone
AC15). Goat anti-rabbit HRP conjugated secondary antibody
was used. Blots were detected with ECL reagent (Perkin Elmer
Life Sciences, Inc.).
GST pull down assay of YopJ
KIM-IKKb interaction
Plasmids for expression of GST-YopJ fusion proteins were
constructed from pLP16 [58]. The pLP16 vector was derived from
pGEX-2T and codes for YopJ
YPTB with an N-terminal glutathi-
one-S transferase (GST) affinity tag and a C-terminal M45 epitope
tag. Quikchange mutagenesis (Invitrogen) was used to introduce
codon changes into pLP16 to generate pGEX-2T-YopJ
KIM,
pGEX-2T-YopJ
KIMC172A and pGEX-2T-YopJ
CO92, which en-
code GST-YopJ
KIM, GST-YopJ
C172A and GST-YopJ
CO92, re-
spectively. The plasmids pGEX-2T, pGEX-2T-YopJ
KIM, pGEX-
2T-YopJ
KIMC172A and pGEX-2T-YopJ
CO92 were used to trans-
form E. coli TUNER cells (Novagen). Cultures of TUNER cells
harboring the above plasmids were grown in LB at 37uCt o
OD600 of 0.2. IPTG was added to 0.1 mM final concentration
and cultures were grown at 18uC with shaking for 4 hrs. The
bacterial pellet obtained from 40 ml of each culture was
resuspended in PBS supplemented with protease inhibitor cocktail
(Roche) and sonicated on ice. The solubility of proteins in the
sonicates was increased by incubation in the presence of a buffer
containing 10% sarkosyl at 4uC overnight [59]. After centrifuga-
tion, the supernatant of the bacterial lysate was diluted 5 times
with a buffer containing 4% Triton X-100 and 40 mM CHAPS at
final concentrations. Thirty ml of glutathione beads (GST Bind
Kit, Novagen) were added and the mixture was shaken at 4uC for
1 hr. Beads were washed 4 times with 1 ml of GST Bind Kit
buffer and used for pull down assays.
Cell lysates containing overexpressed IKKb were prepared from
HEK293T cells tranfected with a retroviral construct (pCLXSN-
IKKb-IRES-GFP) [25]. HEK293T cells were seeded in 10 cm
dishes and grown to reach 70% confluence. The culture medium
was replaced with serum free DMEM and the HEK293T cells in
each dish were transfected with 10 mg of pCLXSN-IKKb-IRES-
GFP using a calcium phosphate method. Six hrs post transfection,
the culture medium was replaced with DMEM containing 10%
FBS. Cells were harvested 48 hrs post transfection, sonicated in
PBS and centrifuged. Supernatants were stored at 280uC until
use.
Beads containing bound GST proteins were incubated with
250 ml of cell lysate supernatants from transfected HEK293T
supernatant for 4 hrs at 4uC with constant rotation. The beads
were then washed 4 times with 1 ml of PBS each and proteins
bound to the beads were eluted in boiling 2X Laemmli sample
buffer. Samples of the eluates were subjected to SDS-PAGE and
immunoblotting. Rabbit polyclonal anti-IKKb antibodies and
mouse monoclonal anti-GST antibodies were purchased from Cell
Signaling and Santa Cruz, respectively. Immunoblot signals
representing IKKb and GST or GST fusion proteins were
quantified using an Odyssey imaging system.
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Experimental data analyzed for significance (GraphPad Prism
4.0) were performed three independent times. Probability (P)
values for multiple comparisons of cytokine, phospho-IkBa ELISA
and LDH release data were calculated by one-way ANOVA and
Tukey’s multiple comparisons post-test. P values for two group
comparisons of cytokine, phospho-IkBa, and phospho-MAPK
ELISA were calculated by two-tailed paired student t test. P values
were considered significant if less than 0.05.
Supporting Information
Text S1 The supporting text includes the supplemental Table
S1, Figures S1-S7, and supplemental experimental procedures.
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